Belgium· BE-AMP-SAM312627-00
Ferriprox 100 mg/ml
A deferiprone product containing deferiprone, registered in Belgium by Chiesi Farmaceutici. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Deferiprone is registered in 16 of 19 countries.
Countries holding a registration under ATC V03AC02 (deferiprone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Deferiprone · ATC V03AC02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferiprone costs, country by country.
Normalised to the WHO defined daily dose (5.25 g), the median price runs from $22.61 in Switzerland to $8636.08 in Italy — a ×382 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferiprone · price per daily dose (5.25 g)
USD · FX 28 Sept 2026
- IT Italy$8636.08
- CH Switzerland$22.61
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Deferiprone
- Manufacturer
- Chiesi Farmaceutici
- Country
- Belgium (BE)
- ATC code
- V03AC02
- ATC class
- Deferiprone
- Defined daily dose
- 5.25 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb2550390EUR 189.07
- be_apb0790220
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for deferiprone.
Graded by severity as the source publishes them — 266 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferiprone · interactions on record
315 records
- 266 severe
- 49 moderate
Most severe, free to view
- FostamatinibB02BX09severe
- ProcainamideC01BA02severe
- TocainideC01BB03severe
- PropylthiouracilH03BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferiprone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFERRIPROXChiesi Farmaceutici S.p.A., Parma
- SpainFERRIPROX 100 MG/ML SOLUCION ORALChiesi Farmaceutici S.P.A.
- FinlandFerriproxChiesi Farmaceutici S.p.A.
- FranceFERRIPROX 100 mg/ml, solution buvableCHIESI FARMACEUTICI
- IrelandFerriprox 100 mg/ml oral solutionChiesi Farmaceutici S.p.A.
- IcelandFerriproxChiesi Farmaceutici S.p.A.*
- NorwayFerriproxChiesi Farmaceutici S.p.a.
- PolandFerriproxChiesi Farmaceutici S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Cyprus · Deferiprone Sapiens
- Denmark · Deferipron Orifarm
- France · Deferiprone Arrow
- United Kingdom (Northern Ireland) · Deferiprone Mercury Pharmaceuticals, Deferiprone Mercury Pharmaceuticals Ltd.
- Greece · Befeprox
- Iceland · Ferriprox
- Italy · Deferiprone Doc
- Liechtenstein · Ferriprox
- Norway · Ferriprox
- Portugal · Befeprox, Deferriprona Generis
- Sweden · Deferipron Evolan, Deferiprone Doc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c35942e-99e8-4c6e-afe6-7ce3c1700540 GET /v1/drugs/7c35942e-99e8-4c6e-afe6-7ce3c1700540?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ferriprox 100 mg/ml",
"name_fr": "Ferriprox 100 mg/ml",
"name_nl": "Ferriprox 100 mg/ml",
"amp_code": "SAM312627-00",
"strengths": [
"100.0000"
],
"pack_count": 2,
"substances": [
"Deferiprone",
"E 110",
"Glycerol",
"Artificial Cherry Flavour Containing Benzyl Alcohol and Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Deferiprone",
"authorisation_numbers": [
"EU/1/99/108/002",
"EU/1/99/108/003"
]
}See everything about deferiprone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.